ARGINASE INHIBITORS AND METHODS OF USE
Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CUMMING, Jared, N LU, Min PALANI, Anandan ACHAB, Abdelghani Abe SO, Sung-Sau CHILDERS, Matthew, L ZHANG, Hongjun FISCHER, Christian SLOMAN, David, L PALTE, Rachel, L PU, Qinglin GATHIAKA, Symon LESBURG, Charles, A LI, Derun SUN, Chunrui GUNAYDIN, Hakan |
| description | Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3765006A4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3765006A4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3765006A43</originalsourceid><addsrcrecordid>eNrjZFBzDHL39HMMdlXw9PPwdPIM8Q8KVnD0c1HwdQ3x8HcJVvB3UwgNduVhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcbmZqYGBmaOJsZEKAEAbt8i_w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ARGINASE INHIBITORS AND METHODS OF USE</title><source>esp@cenet</source><creator>CUMMING, Jared, N ; LU, Min ; PALANI, Anandan ; ACHAB, Abdelghani Abe ; SO, Sung-Sau ; CHILDERS, Matthew, L ; ZHANG, Hongjun ; FISCHER, Christian ; SLOMAN, David, L ; PALTE, Rachel, L ; PU, Qinglin ; GATHIAKA, Symon ; LESBURG, Charles, A ; LI, Derun ; SUN, Chunrui ; GUNAYDIN, Hakan</creator><creatorcontrib>CUMMING, Jared, N ; LU, Min ; PALANI, Anandan ; ACHAB, Abdelghani Abe ; SO, Sung-Sau ; CHILDERS, Matthew, L ; ZHANG, Hongjun ; FISCHER, Christian ; SLOMAN, David, L ; PALTE, Rachel, L ; PU, Qinglin ; GATHIAKA, Symon ; LESBURG, Charles, A ; LI, Derun ; SUN, Chunrui ; GUNAYDIN, Hakan</creatorcontrib><description>Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.</description><language>eng ; fre ; ger</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220223&DB=EPODOC&CC=EP&NR=3765006A4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220223&DB=EPODOC&CC=EP&NR=3765006A4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CUMMING, Jared, N</creatorcontrib><creatorcontrib>LU, Min</creatorcontrib><creatorcontrib>PALANI, Anandan</creatorcontrib><creatorcontrib>ACHAB, Abdelghani Abe</creatorcontrib><creatorcontrib>SO, Sung-Sau</creatorcontrib><creatorcontrib>CHILDERS, Matthew, L</creatorcontrib><creatorcontrib>ZHANG, Hongjun</creatorcontrib><creatorcontrib>FISCHER, Christian</creatorcontrib><creatorcontrib>SLOMAN, David, L</creatorcontrib><creatorcontrib>PALTE, Rachel, L</creatorcontrib><creatorcontrib>PU, Qinglin</creatorcontrib><creatorcontrib>GATHIAKA, Symon</creatorcontrib><creatorcontrib>LESBURG, Charles, A</creatorcontrib><creatorcontrib>LI, Derun</creatorcontrib><creatorcontrib>SUN, Chunrui</creatorcontrib><creatorcontrib>GUNAYDIN, Hakan</creatorcontrib><title>ARGINASE INHIBITORS AND METHODS OF USE</title><description>Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBzDHL39HMMdlXw9PPwdPIM8Q8KVnD0c1HwdQ3x8HcJVvB3UwgNduVhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcbmZqYGBmaOJsZEKAEAbt8i_w</recordid><startdate>20220223</startdate><enddate>20220223</enddate><creator>CUMMING, Jared, N</creator><creator>LU, Min</creator><creator>PALANI, Anandan</creator><creator>ACHAB, Abdelghani Abe</creator><creator>SO, Sung-Sau</creator><creator>CHILDERS, Matthew, L</creator><creator>ZHANG, Hongjun</creator><creator>FISCHER, Christian</creator><creator>SLOMAN, David, L</creator><creator>PALTE, Rachel, L</creator><creator>PU, Qinglin</creator><creator>GATHIAKA, Symon</creator><creator>LESBURG, Charles, A</creator><creator>LI, Derun</creator><creator>SUN, Chunrui</creator><creator>GUNAYDIN, Hakan</creator><scope>EVB</scope></search><sort><creationdate>20220223</creationdate><title>ARGINASE INHIBITORS AND METHODS OF USE</title><author>CUMMING, Jared, N ; LU, Min ; PALANI, Anandan ; ACHAB, Abdelghani Abe ; SO, Sung-Sau ; CHILDERS, Matthew, L ; ZHANG, Hongjun ; FISCHER, Christian ; SLOMAN, David, L ; PALTE, Rachel, L ; PU, Qinglin ; GATHIAKA, Symon ; LESBURG, Charles, A ; LI, Derun ; SUN, Chunrui ; GUNAYDIN, Hakan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3765006A43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CUMMING, Jared, N</creatorcontrib><creatorcontrib>LU, Min</creatorcontrib><creatorcontrib>PALANI, Anandan</creatorcontrib><creatorcontrib>ACHAB, Abdelghani Abe</creatorcontrib><creatorcontrib>SO, Sung-Sau</creatorcontrib><creatorcontrib>CHILDERS, Matthew, L</creatorcontrib><creatorcontrib>ZHANG, Hongjun</creatorcontrib><creatorcontrib>FISCHER, Christian</creatorcontrib><creatorcontrib>SLOMAN, David, L</creatorcontrib><creatorcontrib>PALTE, Rachel, L</creatorcontrib><creatorcontrib>PU, Qinglin</creatorcontrib><creatorcontrib>GATHIAKA, Symon</creatorcontrib><creatorcontrib>LESBURG, Charles, A</creatorcontrib><creatorcontrib>LI, Derun</creatorcontrib><creatorcontrib>SUN, Chunrui</creatorcontrib><creatorcontrib>GUNAYDIN, Hakan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CUMMING, Jared, N</au><au>LU, Min</au><au>PALANI, Anandan</au><au>ACHAB, Abdelghani Abe</au><au>SO, Sung-Sau</au><au>CHILDERS, Matthew, L</au><au>ZHANG, Hongjun</au><au>FISCHER, Christian</au><au>SLOMAN, David, L</au><au>PALTE, Rachel, L</au><au>PU, Qinglin</au><au>GATHIAKA, Symon</au><au>LESBURG, Charles, A</au><au>LI, Derun</au><au>SUN, Chunrui</au><au>GUNAYDIN, Hakan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ARGINASE INHIBITORS AND METHODS OF USE</title><date>2022-02-23</date><risdate>2022</risdate><abstract>Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3765006A4 |
| source | esp@cenet |
| subjects | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ARGINASE INHIBITORS AND METHODS OF USE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T17%3A32%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CUMMING,%20Jared,%20N&rft.date=2022-02-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3765006A4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |